 | • レポートコード：MRC2312MG06689 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、64ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の多臓器マイクロ流体チップ市場規模と予測を収録しています。・世界の多臓器マイクロ流体チップ市場：売上、2018年-2023年、2024年-2029年 ・世界の多臓器マイクロ流体チップ市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の多臓器マイクロ流体チップ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「腸/肝臓チップ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 多臓器マイクロ流体チップのグローバル主要企業は、CN Bio Innovations、 Mimetas、 Draper Laboratory、 Kirkstall、 Netri、 Beijing Daxiang Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、多臓器マイクロ流体チップのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の多臓器マイクロ流体チップ市場：タイプ別、2018年-2023年、2024年-2029年 世界の多臓器マイクロ流体チップ市場：タイプ別市場シェア、2022年 ・腸/肝臓チップ、肺/肝臓チップ、神経/筋肉チップ、心臓/肝臓チップ、その他 世界の多臓器マイクロ流体チップ市場：用途別、2018年-2023年、2024年-2029年 世界の多臓器マイクロ流体チップ市場：用途別市場シェア、2022年 ・製薬、研究機関、その他 世界の多臓器マイクロ流体チップ市場：地域・国別、2018年-2023年、2024年-2029年 世界の多臓器マイクロ流体チップ市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における多臓器マイクロ流体チップのグローバル売上、2018年-2023年 ・主要企業における多臓器マイクロ流体チップのグローバル売上シェア、2022年 ・主要企業における多臓器マイクロ流体チップのグローバル販売量、2018年-2023年 ・主要企業における多臓器マイクロ流体チップのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CN Bio Innovations、 Mimetas、 Draper Laboratory、 Kirkstall、 Netri、 Beijing Daxiang Biotech ************************************************************* ・調査・分析レポートの概要 多臓器マイクロ流体チップ市場の定義 市場セグメント 世界の多臓器マイクロ流体チップ市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の多臓器マイクロ流体チップ市場規模 世界の多臓器マイクロ流体チップ市場規模：2022年 VS 2029年 世界の多臓器マイクロ流体チップ市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの多臓器マイクロ流体チップの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の多臓器マイクロ流体チップ製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：腸/肝臓チップ、肺/肝臓チップ、神経/筋肉チップ、心臓/肝臓チップ、その他 多臓器マイクロ流体チップのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬、研究機関、その他 多臓器マイクロ流体チップの用途別グローバル売上・予測 ・地域別市場分析 地域別多臓器マイクロ流体チップ市場規模 2022年と2029年 地域別多臓器マイクロ流体チップ売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CN Bio Innovations、 Mimetas、 Draper Laboratory、 Kirkstall、 Netri、 Beijing Daxiang Biotech ... |
This research report provides a comprehensive analysis of the Multi-Organ Microfluidic Chip market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Multi-Organ Microfluidic Chip market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Multi-Organ Microfluidic Chip, challenges faced by the industry, and potential opportunities for market players.
The global Multi-Organ Microfluidic Chip market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Multi-Organ Microfluidic Chip market presents opportunities for various stakeholders, including Pharmaceutical, Research Institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Multi-Organ Microfluidic Chip market. Additionally, the growing consumer demand present avenues for market expansion.
The global Multi-Organ Microfluidic Chip market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Multi-Organ Microfluidic Chip market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Multi-Organ Microfluidic Chip market.
Market Overview: The report provides a comprehensive overview of the Multi-Organ Microfluidic Chip market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Gut/Liver-on-a-chip, Lung/Liver-on-a-chip), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Multi-Organ Microfluidic Chip market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Multi-Organ Microfluidic Chip market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Multi-Organ Microfluidic Chip market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Multi-Organ Microfluidic Chip market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Multi-Organ Microfluidic Chip market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Multi-Organ Microfluidic Chip market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Multi-Organ Microfluidic Chip, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Multi-Organ Microfluidic Chip market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Multi-Organ Microfluidic Chip market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Gut/Liver-on-a-chip
Lung/Liver-on-a-chip
Nerve/Muscle-on-a-chip
Heart/Liver-on-a-chip
Others
Market segment by Application
Pharmaceutical
Research Institute
Others
Global Multi-Organ Microfluidic Chip Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CN Bio Innovations
Mimetas
Draper Laboratory
Kirkstall
Netri
Beijing Daxiang Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multi-Organ Microfluidic Chip, market overview.
Chapter 2: Global Multi-Organ Microfluidic Chip market size in revenue.
Chapter 3: Detailed analysis of Multi-Organ Microfluidic Chip company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multi-Organ Microfluidic Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Multi-Organ Microfluidic Chip Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multi-Organ Microfluidic Chip Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multi-Organ Microfluidic Chip Overall Market Size
2.1 Global Multi-Organ Microfluidic Chip Market Size: 2022 VS 2029
2.2 Global Multi-Organ Microfluidic Chip Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Multi-Organ Microfluidic Chip Players in Global Market
3.2 Top Global Multi-Organ Microfluidic Chip Companies Ranked by Revenue
3.3 Global Multi-Organ Microfluidic Chip Revenue by Companies
3.4 Top 3 and Top 5 Multi-Organ Microfluidic Chip Companies in Global Market, by Revenue in 2022
3.5 Global Companies Multi-Organ Microfluidic Chip Product Type
3.6 Tier 1, Tier 2 and Tier 3 Multi-Organ Microfluidic Chip Players in Global Market
3.6.1 List of Global Tier 1 Multi-Organ Microfluidic Chip Companies
3.6.2 List of Global Tier 2 and Tier 3 Multi-Organ Microfluidic Chip Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Multi-Organ Microfluidic Chip Market Size Markets, 2022 & 2029
4.1.2 Gut/Liver-on-a-chip
4.1.3 Lung/Liver-on-a-chip
4.1.4 Nerve/Muscle-on-a-chip
4.1.5 Heart/Liver-on-a-chip
4.1.6 Others
4.2 By Type – Global Multi-Organ Microfluidic Chip Revenue & Forecasts
4.2.1 By Type – Global Multi-Organ Microfluidic Chip Revenue, 2018-2023
4.2.2 By Type – Global Multi-Organ Microfluidic Chip Revenue, 2024-2029
4.2.3 By Type – Global Multi-Organ Microfluidic Chip Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Multi-Organ Microfluidic Chip Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Research Institute
5.1.4 Others
5.2 By Application – Global Multi-Organ Microfluidic Chip Revenue & Forecasts
5.2.1 By Application – Global Multi-Organ Microfluidic Chip Revenue, 2018-2023
5.2.2 By Application – Global Multi-Organ Microfluidic Chip Revenue, 2024-2029
5.2.3 By Application – Global Multi-Organ Microfluidic Chip Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Multi-Organ Microfluidic Chip Market Size, 2022 & 2029
6.2 By Region – Global Multi-Organ Microfluidic Chip Revenue & Forecasts
6.2.1 By Region – Global Multi-Organ Microfluidic Chip Revenue, 2018-2023
6.2.2 By Region – Global Multi-Organ Microfluidic Chip Revenue, 2024-2029
6.2.3 By Region – Global Multi-Organ Microfluidic Chip Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Multi-Organ Microfluidic Chip Revenue, 2018-2029
6.3.2 US Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.3.3 Canada Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.3.4 Mexico Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Multi-Organ Microfluidic Chip Revenue, 2018-2029
6.4.2 Germany Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4.3 France Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4.4 U.K. Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4.5 Italy Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4.6 Russia Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4.7 Nordic Countries Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.4.8 Benelux Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Multi-Organ Microfluidic Chip Revenue, 2018-2029
6.5.2 China Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.5.3 Japan Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.5.4 South Korea Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.5.5 Southeast Asia Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.5.6 India Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Multi-Organ Microfluidic Chip Revenue, 2018-2029
6.6.2 Brazil Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.6.3 Argentina Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Multi-Organ Microfluidic Chip Revenue, 2018-2029
6.7.2 Turkey Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.7.3 Israel Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.7.4 Saudi Arabia Multi-Organ Microfluidic Chip Market Size, 2018-2029
6.7.5 UAE Multi-Organ Microfluidic Chip Market Size, 2018-2029
7 Multi-Organ Microfluidic Chip Companies Profiles
7.1 CN Bio Innovations
7.1.1 CN Bio Innovations Company Summary
7.1.2 CN Bio Innovations Business Overview
7.1.3 CN Bio Innovations Multi-Organ Microfluidic Chip Major Product Offerings
7.1.4 CN Bio Innovations Multi-Organ Microfluidic Chip Revenue in Global Market (2018-2023)
7.1.5 CN Bio Innovations Key News & Latest Developments
7.2 Mimetas
7.2.1 Mimetas Company Summary
7.2.2 Mimetas Business Overview
7.2.3 Mimetas Multi-Organ Microfluidic Chip Major Product Offerings
7.2.4 Mimetas Multi-Organ Microfluidic Chip Revenue in Global Market (2018-2023)
7.2.5 Mimetas Key News & Latest Developments
7.3 Draper Laboratory
7.3.1 Draper Laboratory Company Summary
7.3.2 Draper Laboratory Business Overview
7.3.3 Draper Laboratory Multi-Organ Microfluidic Chip Major Product Offerings
7.3.4 Draper Laboratory Multi-Organ Microfluidic Chip Revenue in Global Market (2018-2023)
7.3.5 Draper Laboratory Key News & Latest Developments
7.4 Kirkstall
7.4.1 Kirkstall Company Summary
7.4.2 Kirkstall Business Overview
7.4.3 Kirkstall Multi-Organ Microfluidic Chip Major Product Offerings
7.4.4 Kirkstall Multi-Organ Microfluidic Chip Revenue in Global Market (2018-2023)
7.4.5 Kirkstall Key News & Latest Developments
7.5 Netri
7.5.1 Netri Company Summary
7.5.2 Netri Business Overview
7.5.3 Netri Multi-Organ Microfluidic Chip Major Product Offerings
7.5.4 Netri Multi-Organ Microfluidic Chip Revenue in Global Market (2018-2023)
7.5.5 Netri Key News & Latest Developments
7.6 Beijing Daxiang Biotech
7.6.1 Beijing Daxiang Biotech Company Summary
7.6.2 Beijing Daxiang Biotech Business Overview
7.6.3 Beijing Daxiang Biotech Multi-Organ Microfluidic Chip Major Product Offerings
7.6.4 Beijing Daxiang Biotech Multi-Organ Microfluidic Chip Revenue in Global Market (2018-2023)
7.6.5 Beijing Daxiang Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
